logo BDSP

Base documentaire


  1. The clinical effectiveness and financial impact of utilizing peripheral blood progenitor cells as rescue therapy following autologous bone marrow transplant.

    Article - En anglais

    The use of peripheral blood progenitor cell transplant as rescue therapy after high-dose chemotherapy and autologous bone marrow transplant significantly decreases transfusion, laboratory, room, and total charges.

    An improvement in clinical indicators also points toward decreased patient morbidity.

    Additional cost reductions may be realized by greater utilization of outpatient care, thereby further reducing room and total charges.

    Mots-clés Pascal : Homogreffe, Moelle osseuse, Homme, Cellule hématopoïétique, Transfusion, Anticancéreux, Dose forte, Toxicité, Evaluation, Analyse coût efficacité, Economie santé, Greffe, Cellule précurseur

    Mots-clés Pascal anglais : Homograft, Bone marrow, Human, Hematopoietic cell, Transfusion, Antineoplastic agent, High dose, Toxicity, Evaluation, Cost efficiency analysis, Health economy, Graft, Progenitor cell

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0240098

    Code Inist : 002B02U02. Création : 199608.